Trade-Ideas LLC identified
) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Healthcare Trust of America as such a stock due to the following factors:
- HTA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $35.1 million.
- HTA has traded 20.40299999999999869260136620141565799713134765625 options contracts today.
- HTA is making at least a new 3-day high.
- HTA has a PE ratio of 104.
- HTA is mentioned 0.74 times per day on StockTwits.
- HTA has not yet been mentioned on StockTwits today.
- HTA is currently in the upper 20% of its 1-year range.
- HTA is in the upper 35% of its 20-day range.
- HTA is in the upper 45% of its 5-day range.
- HTA is currently trading above yesterday's high.
'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in HTA with the Ticky from Trade-Ideas. See the FREE profile for HTA NOW at Trade-Ideas
More details on HTA:
Healthcare Trust of America is a fully integrated, self-administered and internally managed real estate investment trust, or REIT. The company acquires, owns and operates medical office buildings and other facilities that serve the healthcare industry. The stock currently has a dividend yield of 4.3%. HTA has a PE ratio of 104. Currently there are 5 analysts that rate Healthcare Trust of America a buy, no analysts rate it a sell, and 4 rate it a hold.
The average volume for Healthcare Trust of America has been 996,900 shares per day over the past 30 days. Healthcare Trust of America has a market cap of $3.5 billion and is part of the financial sector and real estate industry. The stock has a beta of 0.13 and a short float of 3.5% with 2.34 days to cover. Shares are up 1.4% year-to-date as of the close of trading on Wednesday.
rates Healthcare Trust of America as a
. The company's strengths can be seen in multiple areas, such as its revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company has had sub par growth in net income.
Highlights from the ratings report include:
- Despite its growing revenue, the company underperformed as compared with the industry average of 6.8%. Since the same quarter one year prior, revenues slightly increased by 5.8%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- Net operating cash flow has increased to $52.44 million or 34.62% when compared to the same quarter last year. In addition, HEALTHCARE TRUST OF AMERICA has also vastly surpassed the industry average cash flow growth rate of -73.46%.
- HEALTHCARE TRUST OF AMERICA has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. The company has suffered a declining pattern of earnings per share over the past year. However, we anticipate this trend reversing over the coming year. During the past fiscal year, HEALTHCARE TRUST OF AMERICA reported lower earnings of $0.25 versus $0.37 in the prior year. This year, the market expects an improvement in earnings ($0.37 versus $0.25).
- After a year of stock price fluctuations, the net result is that HTA's price has not changed very much. Although its weak earnings growth may have played a role in this flat result, don't lose sight of the fact that the performance of the overall market, as measured by the S&P 500 Index, was essentially similar. Despite the decline in its share price over the last year, this stock is still more expensive (when compared to its current earnings) than most other companies in its industry. We feel, however, that other strengths this company displays compensate for this.
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Real Estate Investment Trusts (REITs) industry. The net income has significantly decreased by 51.0% when compared to the same quarter one year ago, falling from $21.19 million to $10.37 million.
- You can view the full Healthcare Trust of America Ratings Report.